Compare CVS Health Corp (CVS) vs Intuit Inc. (INTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Intuit Inc. — how do they compare? CVS Health Corp trades at $104.88 (market cap $135.48B), while Intuit Inc. trades at $282.49 (market cap $77.26B). The key difference: CVS Health Corp is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | INTU | |
|---|---|---|
Market Cap | $135.48B | $77.26B |
Sector | Health | Technology |
52-Week High | $106.18 | $807.39 |
52-Week Low | $58.75 | $255.07 |
Enterprise Value | $202.02B | $75.71B |
Dividend Yield | 2.51% | 1.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Intuit (INTU) trades at $282.43, up 2.72% today, with a bullish technical signal but mixed oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $12.8 exceeding expectations. Revenue grew to $18.83B in 2025, and net income margin expanded to 20.54%. However, the stock faces headwinds from multiple law firm investigations into securities fraud allegations related to TurboTax pricing, contributing to a 20% stock drop recently noted by Forbes on June 2, 2026.
The outlook is cautiously optimistic with a consensus price target of $422.88, implying significant upside. Analyst sentiment is 71% buy-rated, but risks include legal overhangs and competitive pressures. Long-term growth drivers like AI integration in Mailchimp and TurboTax Live support fundamentals, yet investors must weigh litigation uncertainties against strong profitability and cash flow trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Intuit Inc.
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of U.S. market share for small-business accounting and DIY tax-filing software.
Read more on INTU →
